RESUMO
Hyperthyroidism is the result of uncontrolled overproduction of the thyroid hormones. One of the mostly used antithyroid agents is 6-n-propyl-2-thiouracil (PTU). The previously solved X-ray crystal structure of the PTU bound to mammalian lactoperoxidase (LPO) reveals that the LPO-PTU binding site is basically a hydrophobic channel. There are two hydrophobic side chains directed towards the oxygen atom in the C-4 position of the thiouracil ring. In the current study, the structural activity relationship (SAR) was performed on the thiouracil nucleus of PTU to target these hydrophobic side chains and gain more favorable interactions and, in return, more antithyroid activity. Most of the designed compounds show superiority over PTU in reducing the mean serum T4 levels of hyperthyroid rats by 3% to 60%. In addition, the effect of these compounds on the levels of serum T3 was found to be comparable to the effect of PTU treatment. The designed compounds in this study showed a promising activity profile in reducing levels of thyroid hormones and follow up experiments will be needed to confirm the use of the designed compounds as new potential antithyroid agents.
Assuntos
Antitireóideos/administração & dosagem , Antitireóideos/síntese química , Hipertireoidismo/tratamento farmacológico , Tiouracila/administração & dosagem , Tiouracila/síntese química , Animais , Antitireóideos/química , Antitireóideos/farmacologia , Sítios de Ligação , Modelos Animais de Doenças , Interações Hidrofóbicas e Hidrofílicas , Hipertireoidismo/sangue , Lactoperoxidase/química , Modelos Moleculares , Ratos , Relação Estrutura-Atividade , Tiouracila/química , Tiouracila/farmacologia , Tri-Iodotironina/sangue , Uracila/análogos & derivados , Uracila/químicaRESUMO
The new silver(I) compound {[AgBr(µ2-S-MMI)(TPP))]2} (1) and the known one [AgCl(TPP)2(MMI)] (2) were obtained by refluxing toluene solutions of silver(I) halide with triphenylphosphine (TPP) and the anti-thyroid drug 2-mercapto-1-methyl-imidazole or methimazole (MMI). The complexes were characterized by m.p., vibrational spectroscopy (mid-FT-IR), (1)H, (31)P-NMR, UV-Vis spectroscopic techniques and X-ray crystallography. The antibacterial effect of 1 and 2 against the bacterial species Pseudomonas aeruginosa (PAO) and Escherichia coli was evaluated. Compound 1 exhibits comparable activity to the corresponding one of the silver nitrate which is an antibacterial drug in use. The in vivo genotoxicity of 1-2 by the mean of Allium cepa test shows no alterations in the mitotic index values due to the absence of chromosomal aberrations. The mechanism of action of the title compounds is evaluated. The DNA binding tests indicate the ability of the complexes 1-2 to modify the activity of the bacteria. The binding constants of 1-2 towards CT-DNA indicate interaction through opening of the hydrogen bonds of DNA. Docking studies on DNA-complexes interactions confirm the binding of both complexes 1-2 in the major groove of the CT-DNA. In conclusion the silver complex 1 is an anti-bacterial and non-genotoxic material, which can be applied to antibacterial drug in the future.
Assuntos
Antibacterianos/síntese química , Antitireóideos/síntese química , Complexos de Coordenação/síntese química , Metimazol/síntese química , Prata/química , Antibacterianos/farmacologia , Antitireóideos/farmacologia , Sítios de Ligação , Complexos de Coordenação/farmacologia , DNA/química , Reposicionamento de Medicamentos , Escherichia coli/efeitos dos fármacos , Escherichia coli/crescimento & desenvolvimento , Ligação de Hidrogênio , Metimazol/farmacologia , Testes de Sensibilidade Microbiana , Índice Mitótico , Simulação de Acoplamento Molecular , Cebolas/citologia , Cebolas/efeitos dos fármacos , Cebolas/genética , Compostos Organofosforados/química , Pseudomonas aeruginosa/efeitos dos fármacos , Pseudomonas aeruginosa/crescimento & desenvolvimento , Nitrato de Prata/farmacologia , Tolueno/químicaRESUMO
Thyroid hormones are essential for the development and differentiation of all cells of the human body. They regulate protein, fat, and carbohydrate metabolism. In this Account, we discuss the synthesis, structure, and mechanism of action of thyroid hormones and their analogues. The prohormone thyroxine (T4) is synthesized on thyroglobulin by thyroid peroxidase (TPO), a heme enzyme that uses iodide and hydrogen peroxide to perform iodination and phenolic coupling reactions. The monodeiodination of T4 to 3,3',5-triiodothyronine (T3) by selenium-containing deiodinases (ID-1, ID-2) is a key step in the activation of thyroid hormones. The type 3 deiodinase (ID-3) catalyzes the deactivation of thyroid hormone in a process that removes iodine selectively from the tyrosyl ring of T4 to produce 3,3',5'-triiodothyronine (rT3). Several physiological and pathological stimuli influence thyroid hormone synthesis. The overproduction of thyroid hormones leads to hyperthyroidism, which is treated by antithyroid drugs that either inhibit the thyroid hormone biosynthesis and/or decrease the conversion of T4 to T3. Antithyroid drugs are thiourea-based compounds, which include propylthiouracil (PTU), methimazole (MMI), and carbimazole (CBZ). The thyroid gland actively concentrates these heterocyclic compounds against a concentration gradient. Recently, the selenium analogues of PTU, MMI, and CBZ attracted significant attention because the selenium moiety in these compounds has a higher nucleophilicity than that of the sulfur moiety. Researchers have developed new methods for the synthesis of the selenium compounds. Several experimental and theoretical investigations revealed that the selone (CâSe) in the selenium analogues is more polarized than the thione (CâS) in the sulfur compounds, and the selones exist predominantly in their zwitterionic forms. Although the thionamide-based antithyroid drugs have been used for almost 70 years, the mechanism of their action is not completely understood. Most investigations have revealed that MMI and PTU irreversibly inhibit TPO. PTU, MTU, and their selenium analogues also inhibit ID-1, most likely by reacting with the selenenyl iodide intermediate. The good ID-1 inhibitory activity of PTU and its analogues can be ascribed to the presence of the -N(H)-C(âO)- functionality that can form hydrogen bonds with nearby amino acid residues in the selenenyl sulfide state. In addition to the TPO and ID-1 inhibition, the selenium analogues are very good antioxidants. In the presence of cellular reducing agents such as GSH, these compounds catalytically reduce hydrogen peroxide. They can also efficiently scavenge peroxynitrite, a potent biological oxidant and nitrating agent.
Assuntos
Antitireóideos/química , Antitireóideos/farmacologia , Antioxidantes/farmacologia , Antitireóideos/síntese química , Modelos Moleculares , Estrutura MolecularAssuntos
Antitireóideos/síntese química , Simportadores/antagonistas & inibidores , Compostos de Anilina/síntese química , Compostos de Anilina/química , Compostos de Anilina/farmacologia , Animais , Antitireóideos/química , Antitireóideos/farmacologia , Transporte Biológico/efeitos dos fármacos , Células Cultivadas , Desenho de Fármacos , Concentração Inibidora 50 , Ratos , Relação Estrutura-Atividade , Simportadores/metabolismoRESUMO
Methimazole (MeimzH) is an anti-thyroid drug and the first choice for patients with Grave's disease. Two new copper(II) complexes of this drug: [Cu(MeimzH)(2)(NO(3))(2)]*0.5H(2)O and [Cu(MeimzH)(2)(H(2)O)(2)](NO(3))(2)*H(2)O were synthesized and characterized by elemental analysis, dissolution behavior, thermogravimetric analysis and UV-vis, diffuse reflectance, FTIR and EPR spectroscopies. As it is known that copper(II) cation can act as an inhibitor of alkaline phosphatase (ALP), the inhibitory effect of methimazole and its copper(II) complexes on ALP activity has also been investigated.
Assuntos
Fosfatase Alcalina/antagonistas & inibidores , Antitireóideos/síntese química , Antitireóideos/metabolismo , Antitireóideos/uso terapêutico , Cobre/química , Doença de Graves/tratamento farmacológico , Metimazol/síntese química , Metimazol/metabolismo , Metimazol/uso terapêutico , Animais , Antitireóideos/química , Espectroscopia de Ressonância de Spin Eletrônica , Humanos , Metimazol/química , Espectrofotometria Ultravioleta , Espectroscopia de Infravermelho com Transformada de FourierAssuntos
Antitireóideos/química , Antitireóideos/farmacologia , Hipertireoidismo/tratamento farmacológico , Receptores da Tireotropina/antagonistas & inibidores , Antitireóideos/síntese química , Humanos , Hipertireoidismo/metabolismo , Peso Molecular , Receptores da Tireotropina/genética , Receptores da Tireotropina/metabolismo , Fatores de TempoRESUMO
Synthesis and biological activity of the antithyroid drug carbimazole (CBZ) and its analogues are described. The introduction of an ethoxycarbonyl group in methimazole and its selenium analogue not only prevents the oxidation to the corresponding disulfide and diselenide but also reduces the zwitterionic character. A structure-activity correlation in a series of CBZ analogues suggests that the presence of a methyl substituent in CBZ and related compounds is important for their antithyroid activity.
Assuntos
Antitireóideos/síntese química , Antitireóideos/farmacologia , Carbimazol/análogos & derivados , Carbimazol/farmacologia , Peroxidase/antagonistas & inibidores , Tirosina/metabolismo , Antitireóideos/química , Carbimazol/química , Catálise/efeitos dos fármacos , Simulação por Computador , Halogenação/efeitos dos fármacos , Estrutura Molecular , Peroxidase/metabolismo , Relação Estrutura-Atividade , Tirosina/químicaRESUMO
Low-molecular-weight (LMW) antagonists for TSH receptor (TSHR) may have therapeutic potential as orally active drugs to block stimulating antibodies (TsAbs) in Graves' hyperthyroidism. We describe an approach to identify LMW ligands for TSHR based on Org41841, a LMW partial agonist for the LH/choriogonadotropin receptor and TSHR. We used molecular modeling and functional experiments to guide the chemical modification of Org41841. We identified an antagonist (NIDDK/CEB-52) that selectively inhibits activation of TSHR by both TSH and TsAbs. Whereas initially characterized in cultured cells overexpressing TSHRs, the antagonist was also active under more physiologically relevant conditions in primary cultures of human thyrocytes expressing endogenous TSHRs in which it inhibited TSH- and TsAb-induced up-regulation of mRNA transcripts for thyroperoxidase. Our results establish this LMW compound as a lead for the development of higher potency antagonists and serve as proof of principle that LMW ligands that target TSHR could serve as drugs in patients with Graves' disease.
Assuntos
Antitireóideos/química , Antitireóideos/farmacologia , Hipertireoidismo/tratamento farmacológico , Receptores da Tireotropina/antagonistas & inibidores , Antitireóideos/síntese química , Linhagem Celular , Células Cultivadas , Simulação por Computador , Humanos , Hipertireoidismo/metabolismo , Estrutura Molecular , Peso Molecular , Mutagênese Sítio-Dirigida , Ligação Proteica/genética , Receptores da Tireotropina/genética , Receptores da Tireotropina/metabolismoRESUMO
Four selenium analogues of the antithyroid drug 6-n-propyl-2-thiouracil (PTU), of formulae RSeU, (R = methyl (Me) (1), ethyl (Et) (2), n-propyl (nPr) (3), and isopropyl (iPr) 4), have been synthesized. Reaction of 1-4 with diiodine in a 1:1 molar ratio in dichloromethane results in the formation of [(RSeU)I(2)] (R = methyl (5), ethyl (6), n-propyl (7) and isopropyl (8)). All compounds have been characterized by elemental analysis, FT-Raman, FT-IR, UV/Vis, (1)H-, (13)C-, (77)Se-1D and -2D NMR spectroscopy, and ESI-MS spectrometric techniques. Recrystallization of 4 from dichloromethane afforded (4CH(2)Cl(2)). Crystals of [(nPrSeU)I(2)] (7), a charge-transfer complex, were obtained from chloroform solutions, while crystallization of 6 and 7 from acetone afforded the diselenides [N-(6-Et-4-pyrimidone)(6-EtSeU)(2)] (92 H(2)O) and [N-(6-nPr-4-pyrimidone)(6-nPrSeU)(2)] (10) as oxidation products. Recrystallization of 7 from methanol/acetonitrile solutions led to deselenation with the formation of 6-n-propyl-2-uracil (nPrU) (11). [(nPrSeU)I(2)] (7) was found to be a charge-transfer complex with a Se--I bond. These results are discussed in relation to the mechanism of action of antithyroid drugs.
Assuntos
Antitireóideos/síntese química , Iodo/química , Compostos Organosselênicos/síntese química , Propiltiouracila/análogos & derivados , Antitireóideos/química , Cristalografia por Raios X , Espectroscopia de Ressonância Magnética , Estrutura Molecular , Compostos Organosselênicos/química , Compostos Organosselênicos/farmacologia , Propiltiouracila/química , Espectrofotometria UltravioletaAssuntos
Propiltiouracila/efeitos adversos , Animais , Antitireóideos/efeitos adversos , Antitireóideos/síntese química , Antitireóideos/química , Antitireóideos/toxicidade , Testes de Carcinogenicidade , Carcinógenos/síntese química , Carcinógenos/química , Carcinógenos/farmacologia , Carcinógenos/toxicidade , Cães , Feminino , Regulamentação Governamental , Guias como Assunto , Humanos , Masculino , Camundongos , Modelos Biológicos , Exposição Ocupacional/efeitos adversos , Exposição Ocupacional/legislação & jurisprudência , Propiltiouracila/síntese química , Propiltiouracila/química , Propiltiouracila/toxicidade , Ratos , Estados UnidosRESUMO
A series of compounds based on the structure of MTI (1-methyl-2-thioimidazole) were synthesized by condensation of alpha-hydroxyketones and alkylthioureas. The alpha-hydroxyketones were obtained by a radical reaction in the presence of sodium and the alkyl ester, while the alkylthioureas were prepared by nucleophilic addition of ammonia on an alkylisothiocyanate. The antithyroid activity of the 13 compounds prepared was evaluated in vitro by determination of the concentrations which led to a 50% inhibition (IC50) of the activity of thyroid peroxidase, and in vivo by assay of thyroid hormones levels and histological examination of the thyroid gland in rats treated chronically with the compounds. 1-methyl-4,5-dipropyl 2-thioimidazole (compound 10) was found to have the highest antithyroid activity of the 13 compounds synthesized.
Assuntos
Antitireóideos/síntese química , Imidazóis/síntese química , Animais , Antitireóideos/farmacologia , Imidazóis/farmacologia , Técnicas In Vitro , Iodeto Peroxidase/antagonistas & inibidores , Lactoperoxidase/antagonistas & inibidores , Espectroscopia de Ressonância Magnética , Masculino , Ratos , Ratos Wistar , Espectrofotometria Infravermelho , Glândula Tireoide/química , Glândula Tireoide/efeitos dos fármacosRESUMO
Different 1-aryl-2-benzylmercapto-4-phenyl-1,6-dihydro-1,3,5-triazine-6- thiones have been synthesized by known methods. These triazines on treatment with ammonia/hydrazine hydrate afforded the corresponding 1-aryl-2-amino/hydrazino-4-phenyl-1,6-dihydro-1,3,5-triazine-6-thiones which on treatment with arylisothiocyanates afforded the related thiocarbamide/thiosemicarbazides. Some of these compounds show appreciable antithyroidal activity.
Assuntos
Antitireóideos/síntese química , Triazinas/síntese química , Animais , Antitireóideos/farmacologia , Ratos , Tiouracila/farmacologia , Triazinas/farmacologiaRESUMO
A series of compounds was synthesized by linking various derivatives of pyridine, pyrimidine or pyrazine to thiazole-2-thiol or to its partially hydrogenated derivative 2-thiazoline-2-thiol. The reactions of the compounds with molecular iodine and lactoperoxidase were examined in vitro. Their antithyroid activity was also examined in vivo in the rat. T4 and TSH levels were determined, and the thyroid gland was examined histologically. 2-(3-Hydroxy-2-pyridyl)-2-thiothiazoline had the highest antithyroid activity of the compounds tested (Kc = 14931.mol(-1),IC(50)0.65 x 10(-4) M, activity of thyroid gland).
Assuntos
Antitireóideos/síntese química , Piridinas/síntese química , Tiazóis/síntese química , Animais , Antitireóideos/química , Antitireóideos/farmacologia , Masculino , Pirazinas/química , Piridinas/química , Piridinas/farmacologia , Pirimidinas/química , Ratos , Ratos Wistar , Tiazóis/química , Tiazóis/farmacologia , Tireotropina/sangue , Tiroxina/sangueRESUMO
It has been demonstrated spectroscopically that many nitrogen-containing heterocyclic compounds can form charge transfer complexes with iodine. The complexes of morpholine with iodine were shown to be of the n-sigma type with a 1:1 stoichiometry. A strong donor-acceptor interaction was found (Kc = 1261 +/- 12 mol-1 at 20 degrees C in CCl4), considerably higher than those of complexes of aromatic compounds with iodine. The high value of the formation constant for this complex indicated that morpholine could serve as a starting point for the synthesis of novel anti-thyroid drugs.
Assuntos
Antitireóideos/síntese química , Iodo/química , Morfolinas/química , EspectrofotometriaRESUMO
A number of compounds of pharmaceutical importance from a variety of chemical families, including thiocyanates, isothiocyanates, thiourea and derivatives, imidazoles, and various amines, were found to form charge transfer complexes with iodine. Parallel studies were carried out to investigate the actions of these drugs on lactoperoxidase and thyroid activity in vivo in the rat (assays of T3 and T4 and histology of the thyroid gland). The results showed that there was a good correlation between the value of Kc (the formation constant of the iodinated complex) and antithyroid activity in vivo. The higher the electron donor power of the compound, the higher the Kc value and the stronger the action on the thyroid. The results indicated that a number of drugs could have secondary antithyroid activity. Some compounds, such as levamisole, tetramethylthiourea, tetrahydrozoline, phenothiazines, and imipramines, with no action on peroxidase had high Kc values (tetramethylthiourea, 13,825 liters/M) and had strong antithyroid activity in the rat. These results suggest that synthetic antithyroid agents may act either on peroxidase and/or the molecular iodine which may be produced by oxidation of iodides (2I(-)----I2----2I+). It has been shown that oxidation of I- can occur in the absence of thyroglobulin. In the absence of a suitable receptor, significant amounts of I2 may, thus, accumulate. The action of such drugs on molecular iodine may have considerable pharmacological significance.
Assuntos
Antitireóideos/farmacologia , Iodetos/metabolismo , Iodo/metabolismo , Absorção , Animais , Antitireóideos/síntese química , Antitireóideos/metabolismo , Fenômenos Biomecânicos , Fenômenos Químicos , Química , Ativação Enzimática , Lactoperoxidase/metabolismo , Masculino , Oxirredução , Ratos , Tioureia/análogos & derivados , Tioureia/farmacologia , Tiroxina/sangue , Tri-Iodotironina/sangue , Raios UltravioletaRESUMO
A change in ideas concerning the use of radioactive iodine in the treatment of hyperthyroidism has revived interest in this therapy. We report the results of an enquiry conducted in all French nuclear medicine units regarding their activity in 1985 and compare these results with those of a similar enquiry conducted simultaneously in Belgium. The amount of radioactive iodine administered in France was one-half of that administered in Belgium. Regional differences were quite marked in France, probably due to different schools of thought. Diffuse hyperthyroidism accounted for two-thirds of the indications. Most patients received one single dose. The primary objective was a return to euthyroidism, but one third of the units accepted the risk of hypothyroidism. Synthetic antithyroid drugs were often used as adjuvants. In one-half of the units, the radioactive dose administered to each patient was calculated from the effective period of the radioelement and from the thyroid mass. In 1 out of 3 units the patients were hospitalized in a controlled area for a mean period of 3 days. French doctors generally respected the 40-year age limit and systematically excluded children and teenagers. Long-term follow-up was carried out in only 50 per cent of the units.
Assuntos
Hipertireoidismo/tratamento farmacológico , Radioisótopos do Iodo/uso terapêutico , Antitireóideos/síntese química , Antitireóideos/uso terapêutico , França , Inquéritos Epidemiológicos , Humanos , Radioisótopos do Iodo/administração & dosagem , Serviço Hospitalar de Medicina NuclearRESUMO
The administration of synthetic antithyroid drugs or of l131, and subtotal resection of the thyroid gland remain the treatments of hyperthyroidism. Precise criteria will determine the choice. Surgery is the treatment of large goitres, of associated ophthalmic disorders and of recurrence after medical treatment. Drugs are indicated at the first occurrence of hyperthyroidism in young subjects with a small goitre; it will also be used as a preparation for surgery associated to Lugol and Levothyroxine. Finally l131 is indicated in medium size hyperthyroid goitres in patients over 45 years. Each treatment has advantages and drawbacks which must be taken into account for the therapeutic choice and the follow-up.